141 related articles for article (PubMed ID: 11689147)
41. Telomerase activity, cytokeratin 20 and cytokeratin 19 in urine cells of bladder cancer patients.
Morsi MI; Youssef AI; Hassouna ME; El-Sedafi AS; Ghazal AA; Zaher ER
J Egypt Natl Canc Inst; 2006 Mar; 18(1):82-92. PubMed ID: 17237854
[TBL] [Abstract][Full Text] [Related]
42. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
[TBL] [Abstract][Full Text] [Related]
43. [Telomerase].
Tsuji N; Watanabe N
Rinsho Byori; 2002 Nov; Suppl 123():137-41. PubMed ID: 12652801
[TBL] [Abstract][Full Text] [Related]
44. Expression of telomerase hTERT in human non-small cell lung cancer and its correlation with c-myc gene.
Geng Z; Zhang D; Liu Y
Chin Med J (Engl); 2003 Oct; 116(10):1467-70. PubMed ID: 14570602
[TBL] [Abstract][Full Text] [Related]
45. Telomerase activity determined by conventional telomeric repeat amplification protocol and reverse transcriptase-polymerase chain reaction assay in ovarian lesions: a comparison of assays.
Ernst A; Okkels H; Grove A; Svarrer T; Knudsen A; Madsen PH; Krarup HB
Scand J Clin Lab Invest; 2006; 66(4):287-97. PubMed ID: 16777757
[TBL] [Abstract][Full Text] [Related]
46. Detection of hTERT mRNA in colonic brush specimens as an adjunct to cytopathologic diagnosis of colonic adenocarcinoma.
Li SQ; Sheng ZM; Baili Y; Erozan YS; O'Leary TJ
Acta Cytol; 2002; 46(6):1069-74. PubMed ID: 12462084
[TBL] [Abstract][Full Text] [Related]
47. [Quantitative analysis of telomerase activity in exfoliated urothelial cells for the diagnosis of bladder carcinoma].
Yokota K; Kanayama H; Kagawa S; Abe-Hashimoto J; Hirose M; Yoshimura T
Nihon Rinsho; 1998 May; 56(5):1292-8. PubMed ID: 9613140
[TBL] [Abstract][Full Text] [Related]
48. Expression of a recombinant vector of a mutant human telomerase reverse transcriptase gene in human bladder cancer cell line T24, and its clinical significance.
Fu WJ; Hong BF; Huang JJ; Xu B; Gao JP; Wang XX; Huang CF
BJU Int; 2005 Oct; 96(6):890-4. PubMed ID: 16153224
[TBL] [Abstract][Full Text] [Related]
49. Telomerase activity and hTERT mRNA expression in body fluids.
Yamamoto Y; Hirakawa E
Diagn Cytopathol; 2005 Mar; 32(3):167-70. PubMed ID: 15690332
[TBL] [Abstract][Full Text] [Related]
50. Telomerase in (pre)neoplastic cervical disease.
Wisman GB; De Jong S; Meersma GJ; Helder MN; Hollema H; de Vries EG; Keith WN; van der Zee AG
Hum Pathol; 2000 Oct; 31(10):1304-12. PubMed ID: 11070123
[TBL] [Abstract][Full Text] [Related]
51. Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase transcription and telomerase activity.
Zou L; Zhang P; Luo C; Tu Z
Urology; 2006 Jun; 67(6):1335-40. PubMed ID: 16765199
[TBL] [Abstract][Full Text] [Related]
52. Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer.
Ito H; Kyo S; Kanaya T; Takakura M; Inoue M; Namiki M
Clin Cancer Res; 1998 Jul; 4(7):1603-8. PubMed ID: 9676833
[TBL] [Abstract][Full Text] [Related]
53. Quantification of hTERT mRNA and telomerase activity in bladder washings of patients with recurrent urothelial cell carcinomas.
de Kok JB; van Balken MR; Roelofs RW; van Aarssen YA; Swinkels DW; Klein Gunnewiek JM
Clin Chem; 2000 Dec; 46(12):2003-7. PubMed ID: 11106338
[No Abstract] [Full Text] [Related]
54. Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer.
Lledó SM; Garcia-Granero E; Dasí F; Ripoli R; García SA; Cervantes A; Aliño SF
Colorectal Dis; 2004 Jul; 6(4):236-42. PubMed ID: 15206965
[TBL] [Abstract][Full Text] [Related]
55. Relative expression of human telomerase catalytic subunit (hTERT) transcripts in astrocytic gliomas.
Kotoula V; Barbanis S; Nikolakaki E; Koufoyannis D; Papadimitriou CS; Karkavelas G
Acta Neuropathol; 2004 May; 107(5):443-51. PubMed ID: 14986029
[TBL] [Abstract][Full Text] [Related]
56. The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine.
Siracusano S; Niccolini B; Knez R; Tiberio A; Benedetti E; Bonin S; Ciciliato S; Pappagallo GL; Belgrano E; Stanta G
Eur Urol; 2005 Mar; 47(3):327-33. PubMed ID: 15716196
[TBL] [Abstract][Full Text] [Related]
57. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
El-Mazny A; Sayed M; Sharaf S
Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049
[TBL] [Abstract][Full Text] [Related]
58. High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma.
Hiyama E; Yamaoka H; Matsunaga T; Hayashi Y; Ando H; Suita S; Horie H; Kaneko M; Sasaki F; Hashizume K; Nakagawara A; Ohnuma N; Yokoyama T
Br J Cancer; 2004 Aug; 91(5):972-9. PubMed ID: 15280920
[TBL] [Abstract][Full Text] [Related]
59. Comparison of screening methods in the detection of bladder cancer.
Ramakumar S; Bhuiyan J; Besse JA; Roberts SG; Wollan PC; Blute ML; O'Kane DJ
J Urol; 1999 Feb; 161(2):388-94. PubMed ID: 9915409
[TBL] [Abstract][Full Text] [Related]
60. Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissues.
Yano Y; Yoshida K; Osaki A; Toge T; Tahara H; Ide T; Yasui W
Anticancer Res; 2002; 22(6C):4101-7. PubMed ID: 12553039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
